From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets

This study is testing a mobile phone app designed to help people with hepatitis D (HDV) manage their health. The app lets patients track lab results, answer quality-of-life questions, and communicate with their doctors between visits. The main goal is to see if using the app help…

This study follows a small group of Italian patients with Polycythemia Vera, a chronic blood cancer, who previously responded well to the drug Ropeginterferon alfa-2b. The goal is to see if the treatment's benefits, like controlling blood counts and preventing complications, are …

This study is testing a new digital app designed to help young people (ages 14-20) who have had or are waiting for a liver transplant. The app helps them manage their health and medications, especially as they move from pediatric to adult care. Researchers want to see if the app …

This study aims to understand why some patients with a blood cancer called essential thrombocythemia (ET) later develop a related cancer called polycythemia vera (PV). Researchers will look back at the medical records of 678 patients to identify risk factors for this change and c…

This study is testing a new, automatic screening method to find more people who have Hepatitis Delta, a severe form of liver disease. It will involve about 244 people in Bergamo, Italy, who are already known to have Hepatitis B. The main goal is to see how many of these people al…

This study aims to gather detailed information on how myelofibrosis, a rare and serious bone marrow cancer, affects patients in everyday clinical practice. It will follow over 600 patients across Europe for several years, tracking their health, treatments, and quality of life. Th…